CoChat

Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells

Open access
Zhang, Ai-Hong, Yoon, Jeongheon, Kim, Yong Chan, Scott, David W · 2018 · The Journal of Immunology
Cited by 63

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Controlling immune responses in autoimmunity and to biotherapeutics is an unmet need. In hemophilia, for example, up to one third of patients receiving therapeutic factor VIII (FVIII) infusions develop neutralizing Abs termed “inhibitors.” To address this problem in a mouse model of hemophilia A, we used an Ag-specific regulatory T cell (Treg) approach in which we created a novel B cell–targeting chimeric receptor composed of an FVIII Ag domain linked with the CD28-CD3ζ transmembrane and signaling domains. We termed these “BAR” for B cell–targeting Ab receptors. CD4+CD25hiCD127low human Tregs were retrovirally transduced to express a BAR containing the immunodominant FVIII C2 or A2 domains (C2- and A2-BAR). Such BAR-Tregs specifically suppressed the recall Ab response of spleen cultures from FVIII-immunized mice in vitro and completely prevented anti-FVIII Ab development in response to FVIII immunization. Mechanistic studies with purified B cells and T cells from tolerized or control recipients demonstrated that the FVIII-specific B cells were directly suppressed or anergized, whereas the T cell response remained intact. Taken together, we report in this study a successful proof-of-principle strategy using Ag-expressing Tregs to directly target specific B cells, an approach which could be adapted to address other adverse immune responses as well.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1701800

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 41

  1. Vignali, 2008, How regulatory T cells work, Nat. Rev. Immunol., 8, 523, 10.1038/nri2343 · DOI · Paper page
  2. Bluestone, 2005, Regulatory T-cell therapy: is it ready for the clinic?, Nat. Rev. Immunol., 5, 343, 10.1038/nri1574 · DOI · Paper page
  3. Tang, 2012, CD4(+)Foxp3(+) regulatory T cell therapy in transplantation, J. Mol. Cell Biol., 4, 11, 10.1093/jmcb/mjr047 · DOI · Paper page
  4. Brunstein, 2013, Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation, Biol. Blood Marrow Transplant., 19, 1271, 10.1016/j.bbmt.2013.06.004 · DOI · Paper page
  5. Brusko, 2010, Human antigen-specific regulatory T cells generated by T cell receptor gene transfer, PLoS One, 5, e11726, 10.1371/journal.pone.0011726 · DOI · Paper page
  6. MacDonald, 2016, Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor, J. Clin. Invest., 126, 1413, 10.1172/JCI82771 · DOI · Paper page
  7. Ettinger, 2009, Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses, Blood, 114, 1423, 10.1182/blood-2009-01-200725 · DOI · Paper page
  8. Kim, 2015, Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses, Blood, 125, 1107, 10.1182/blood-2014-04-566786 · DOI · Paper page
  9. Qian, 2000, Prevention and treatment of factor VIII inhibitors in murine hemophilia A, Blood, 95, 1324, 10.1182/blood.V95.4.1324.004k25_1324_1329 · DOI · Paper page
  10. Bi, 1995, Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A, Nat. Genet., 10, 119, 10.1038/ng0595-119 · DOI · Paper page
  11. Kim, 2012, Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion, Blood, 119, 2810, 10.1182/blood-2011-09-377895 · DOI · Paper page
  12. Hausl, 2004, Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders, Blood, 104, 115, 10.1182/blood-2003-07-2456 · DOI · Paper page
  13. Zhang, 2011, Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice, Blood, 117, 2223, 10.1182/blood-2010-06-293324 · DOI
  14. Lollar, 2004, Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX, J. Thromb. Haemost., 2, 1082, 10.1111/j.1538-7836.2004.00802.x · DOI
  15. Scandella, 1988, Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli, Proc. Natl. Acad. Sci. USA, 85, 6152, 10.1073/pnas.85.16.6152 · doi:10.1073/pnas.85.16.6152
  16. Lei, 2005, Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins, Blood, 105, 4865, 10.1182/blood-2004-11-4274 · DOI · Paper page
  17. Bray, 1993, Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the multi-center hemophilia cohort study, Am. J. Hematol., 42, 375, 10.1002/ajh.2830420408 · DOI · Paper page
  18. Evans, 1998, Development of autoantibodies and factor VIII inhibitor in an HIV-infected haemophiliac following treatment with combination anti-retroviral therapy, Br. J. Haematol., 102, 1382, 10.1046/j.1365-2141.1998.00985.x · doi:10.1046/j.1365-2141.1998.00985.x
  19. Matsui, 2009, A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells, Blood, 114, 677, 10.1182/blood-2009-03-202267 · DOI · Paper page
  20. Sack, 2012, Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy, PLoS One, 7, e37671, 10.1371/journal.pone.0037671 · DOI · Paper page
  21. Lei, 2005, Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold, Cell. Immunol., 235, 12, 10.1016/j.cellimm.2005.06.007 · DOI
  22. Peng, 2009, Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy, Blood, 114, 4373, 10.1182/blood-2009-05-217315 · DOI · Paper page
  23. Waters, 2009, Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response, Blood, 113, 193, 10.1182/blood-2008-04-151597 · DOI · Paper page
  24. Oliveira, 2013, Adjuvant facilitates tolerance induction to factor VIII in hemophilic mice through a Foxp3-independent mechanism that relies on IL-10, Blood, 121, 3936, 10.1182/blood-2012-09-457135 · DOI
  25. Moghimi, 2011, Induction of tolerance to factor VIII by transient co-administration with rapamycin, J. Thromb. Haemost., 9, 1524, 10.1111/j.1538-7836.2011.04351.x · DOI · Paper page
  26. Liu, 2014, Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII, J. Thromb. Haemost., 12, 921, 10.1111/jth.12576 · DOI
  27. Wang, 2015, Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells, Blood, 125, 2418, 10.1182/blood-2014-08-597070 · DOI · Paper page
  28. Sarkar, 2014, Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia, Mol. Ther. Methods Clin. Dev., 1, 14030, 10.1038/mtm.2014.30 · DOI · Paper page
  29. Hausl, 2005, High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors, Blood, 106, 3415, 10.1182/blood-2005-03-1182 · DOI · Paper page
  30. Ellebrecht, 2016, Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease, Science, 353, 179, 10.1126/science.aaf6756 · DOI · Paper page
  31. Bystry, 2001, B cells and professional APCs recruit regulatory T cells via CCL4, Nat. Immunol., 2, 1126, 10.1038/ni735 · DOI · Paper page
  32. Zhao, 2006, Activated CD4+CD25+ T cells selectively kill B lymphocytes, Blood, 107, 3925, 10.1182/blood-2005-11-4502 · DOI · Paper page
  33. Gotot, 2012, Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo, Proc. Natl. Acad. Sci. USA, 109, 10468, 10.1073/pnas.1201131109 · DOI
  34. Gondek, 2005, Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism, J. Immunol., 174, 1783, 10.4049/jimmunol.174.4.1783 · DOI · Paper page
  35. Ashley, 2009, Cutting edge: responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B, J. Immunol., 183, 4843, 10.4049/jimmunol.0900845 · DOI
  36. Tran, 2009, Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function, J. Immunol., 182, 2929, 10.4049/jimmunol.0803827 · DOI
  37. Klein, 2003, In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro, Proc. Natl. Acad. Sci. USA, 100, 8886, 10.1073/pnas.1533365100 · DOI · Paper page
  38. Brudno, 2016, Toxicities of chimeric antigen receptor T cells: recognition and management, Blood, 127, 3321, 10.1182/blood-2016-04-703751 · DOI · Paper page
  39. Sakemura, 2016, A Tet-on inducible system for controlling CD19-chimeric antigen receptor expression upon drug administration, Cancer Immunol. Res., 4, 658, 10.1158/2326-6066.CIR-16-0043 · DOI · Paper page
  40. Foster, 2017, Regulated expansion and survival of chimeric antigen receptor-modified T cells using small molecule-dependent inducible MyD88/CD40, Mol. Ther., 25, 2176, 10.1016/j.ymthe.2017.06.014 · DOI · Paper page
  41. Straathof, 2005, An inducible caspase 9 safety switch for T-cell therapy, Blood, 105, 4247, 10.1182/blood-2004-11-4564 · DOI · Paper page

Cited by

See all 63

Metadata

Authors
Zhang, A.-H., Yoon, J., Kim, Y. C., & Scott, D. W.
Venue
The Journal of Immunology
Published
2018-09-01
Volume
201
Issue
5
Pages
1434-1441
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2883538026
Cited by
63
References
4
FWCI
2.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells. https://app.cochat.ai/papers/10.4049/jimmunol.1701800
The paper
Zhang, A.-H., Yoon, J., Kim, Y. C., & Scott, D. W. (2018). Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1701800

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.